Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;4(2):3-15.
doi: 10.18001/TRS.4.2.1.

Biomarkers of Exposure in ENDS Users, Smokers, and Dual Users of American Indian Descent

Affiliations

Biomarkers of Exposure in ENDS Users, Smokers, and Dual Users of American Indian Descent

Dana Mowls Carroll et al. Tob Regul Sci. 2018 Mar.

Abstract

Objectives: We measured biomarkers of exposure among American Indian (AI) ENDS users, smokers, and dual users.

Methods: Urine was analyzed for total nicotine equivalents (TNE) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol(NNAL). Expired-air carbon monoxide (CO) was collected. Two analyses were performed. "CO analysis" included smokers and dual users whose CO was ≥ 6 ppm and ENDS users whose CO was < 6 ppm. "NNAL analysis" included smokers and dual users whose NNAL was ≥ 47.3 pg/mg, and ENDS users whose NNAL was < 47.3 pg/mg. Biomarkers were summarized by geometric means (GM) and compared with nonparametric tests.

Results: In both analyses, TNE was no different across the groups, and NNAL and CO were lower in ENDS users. In the NNAL analysis the GM of NNAL was 261.4, 6.1, and 228.0 pg/mg among smokers, ENDS users, and dual users (p < .001). Also in the NNAL analysis, the GM of CO was 14.7, 2.4, and 16.8 ppm among smokers, ENDS users, and dual users (p < .001).

Conclusions: ENDS users did not differ in nicotine and had lower exposure to a lung carcinogen and a cardiovascular toxicant than smokers or dual users. Dual users and smokers did not differ in biomarker levels. Results should be used to inform tribal regulations and to educate the AI community on ENDS.

Keywords: American Indian; ENDS; biomarkers; e-cigarette.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement None declared.

Figures

Figure 1
Figure 1
Overview of Inclusion Criteria for CO and NNAL Analysis Sets Note. Based on a given participant’s CO and NNAL levels, they may be included in both analyses, excluded in both analyses, or included in one analysis but not the other.
Figure 2.
Figure 2.
Geometric Mean and 95% Confidence Interval of TNE, total NNAL, and CO by User Group

References

    1. Grana R, Benowitz N, Glantz SA. E-cigarettes a scientific review. Circulation. 2014;129(19):1972–1986. - PMC - PubMed
    1. Walton KM, Abrams DB, Bailey WC, et al. NIH electronic cigarette workshop: developing a research agenda. Nicotine Tob Res. 2015;17(2):259–269. - PMC - PubMed
    1. Chen IL. FDA summary of adverse events on electronic cigarettes. Nicotine Tob Res. 2013;15(2):615–616. - PubMed
    1. National Institutes of Health, Food and Drug Adminstration. PATH Study Data Collection Instruments. PATH Study Data Collection Questionnaires. Available at: http://www.reginfo.gov/public/do/PRAViewIC?ref_nbr=201407-0925-004&icID=.... Accessed October 31, 2017.
    1. US Centers for Disease Control and Prevention. E-cigarettes: An Emerging Public Health Challenge. Public Health Grand Rounds. 2015. Available at: http://www.cdc.gov/cdcgrandrounds/archives/2015/october2015.htm. Accessed October 6, 2015.

LinkOut - more resources